Kim Keck, Director at Evolent Health, Inc. (EVH), bought 21,080 shares at $9.44 ($199K) on 2025-03-07, disclosed to the SEC on 2025-03-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.44 | 10,540 | $99K | 50.0% |
| 2 | $9.44 | 10,540 | $99K | 50.0% |
| Total | $9.44 avg | 21,080 | $199K | 100% |
| Filing → |